Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AD-116
- Development stage
- Phase 1
- Lead developer
- Addpharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AD-116 is a new molecular entity under development by Addpharma for the treatment of benign prostatic hyperplasia[7]. Its precise mechanism of action has not yet been defined in publicly available sources, and no target, pharmacology, or molecular structure information is currently disclosed[7][2][6][10]. Preclinical studies are underway in South Korea, and a phase I clinical trial is planned for healthy adult male volunteers to assess safety and pharmacokinetics (NCT07103278)[7][2][6][10]. There are no published data indicating use for other diseases or expanded indications. No evidence currently suggests AD-116 is a combination product, biosimilar, generic, reformulation, or dietary supplement.
- Other names
- AD 116AD116AD-116
02
Targets
ADRA1B (α1B)ADRA1D (α1D)SRD5A2 (Steroid 5-alpha-reductase type II)SRD5A1 (Steroid 5-alpha-reductase type 1)ADRA1A (α1A)
Beyond the preview
Go deeper on AD-116.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AD-116.